-
Mashup Score: 1Mutation Clearance After Allogeneic Stem Cell Transplantation as Prognostic Indicator for Patients With Myelofibrosis - 8 day(s) ago
For patients with myelofibrosis undergoing allogeneic hematopoietic stem cell transplantation, mutation driver clearance at 30 days was associated with improved cancer outcomes, according to study results.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Study Fails to Validate Perineural Invasion Score as a Predictor of Adverse Events in cSCC - 8 day(s) ago
The study sought to validate the Totonchy et al. findings, which previously demonstrated a positive correlation between a higher perineural invasion score and increased risk of adverse events.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, DermatologyTweet-
PNI Score Not a Reliable Predictor in cSCC A #AAD2025 study found no significant link between perineural invasion (PNI) score and adverse events in cutaneous SCC. https://t.co/FsdCWjqTfS #Derm #SkinCancer #PNIScore #DermResearch
-
-
Mashup Score: 0Loncastuximab Tesirine Plus Rituximab Demonstrates Efficacy and Tolerability for Treatment of R/R Follicular Lymphoma - 9 day(s) ago
For patients with relapsed/refractory follicular lymphoma who experience relapse within 24 months after first-line treatment, loncastuximab tesirine plus rituximab shows efficacy and safety, according to a phase 2 trial.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, Oncologists1Tweet-
For patients with relapsed/refractory #FL who experience relapse within 24 months after first-line treatment, loncastuximab tesirine plus #rituximab shows efficacy and safety. Learn more: https://t.co/TstPIBSkwU https://t.co/VR7lsRIj7N
-
-
Mashup Score: 1
Test your knowledge on how pollution, detergents, and food additives contribute to barrier damage, type 2 inflammation, and food allergies.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, DermatologyTweet-
How Well Do You Know #EnvironmentalTriggers of Barrier Damage & Type 2 Inflammation? Test your knowledge on how pollution, detergents, and food additives contribute to #BarrierDamage, #Type2Inflammation, and food allergies. https://t.co/xR75gWpJpx #Dermatology #Eczema
-
-
Mashup Score: 15
Even though crossing aortic valves isn’t a lost art, crossing may be more difficult for novice operators because of a lack of everyday practice in the cath lab.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, Cardiology News and JournTweet-
Crossing Stenotic Aortic Valves During TAVR: Technical Review and Thoughts Richard Casazza, MAS, RT(R)(CI) https://t.co/IJ53x0m9Iz #cardiotwitter @InvasiveCardiol https://t.co/0vDmtg71v9
-
-
Mashup Score: 0Impact of Laser Refraction and Ambient Light on Sensor-Based Automatic Hand Sanitizer Dispensers - 11 day(s) ago
Cosmetic lasers are commonly used in dermatology in several settings, including academic dermatology. In many academic dermatology settings, the rooms where laser treatments are conducted have sensor-based automatic hand sanitizer and soap dispensers in place.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, DermatologyTweet-
#LaserTreatments & Sanitizer Malfunctions? Did you know that Nd:YAG lasers might trigger automatic hand sanitizer dispensers? A new commentary explores how laser refraction and electromagnetic interference could lead to unwanted dispensing. https://t.co/9O7AJdAVjC #Dermatology
-
-
Mashup Score: 0Western Atrial Fibrillation Symposium - 12 day(s) ago
Returning to Park City, Utah, for its 17th year, this internationally recognized CME meeting unites colleagues and cohorts in the atrial fibrillation community for state of the science education. This program, with attendees spanning more than 25 different countries, brings together expert faculty who will feature lectures on the latest advancements in diagnosis and treatment, challenging case studies, and fireside chats for group discussions.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, CardiologistsTweet-
#EPeeps, live case recordings from #WAFib2025 are now available on the @westernAFIB newsroom! 🎥✨ Catch all the expert insights, groundbreaking discussions, and key highlights. Don’t miss out—watch now! https://t.co/MrkH2E5Gz6 @nmarrouche https://t.co/gO2ze7WEZt
-
-
Mashup Score: 0Venetoclax and Hypomethylating Agent Treatment Shows Efficacy for R/R Acute Myeloid Leukemia, With Genetic Predictors of Response Identified - 12 day(s) ago
Venetoclax plus hypomethylating agents demonstrated efficacy for treating R/R AML, with genetic features, including distinct mutations, predicting response to treatment, according to a retrospective study.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, Oncologists1Tweet-
#Venetoclax plus hypomethylating agents demonstrated efficacy for treating R/R #AML, with genetic features, including distinct mutations, predicting response to treatment. Learn more: https://t.co/sr9LBqY6wq https://t.co/78MPvwYVP2
-
-
Mashup Score: 0Glucagon-Like Peptide-1 Receptor Agonists: A New Frontier in Atrial Fibrillation Treatment - 16 day(s) ago
Linda Moulton, RN, MS, reviews the characteristics of epicardial adipose tissue, its impact on atrial fibrillation, the action of glucagon-like peptide-1 receptor agonists to alter that fat, and drug side effects.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, Cardiology News and JournTweet-
New on the #AFib Topic Center! 👉 "Glucagon-Like Peptide-1 Receptor Agonists: A New Frontier in Atrial Fibrillation Treatment" Explore the latest research on this emerging therapy and its potential to reshape AF management. 🫀 https://t.co/VrzV5EpkPZ https://t.co/gAEeSWw4du
-
-
Mashup Score: 0Autologous Hematopoietic Stem Cell Transplantation as Additional Treatment Option for Secondary Acute Myeloid Leukemia - 16 day(s) ago
While allogeneic hematopoietic stem cell transplantation is the standard treatment for secondary AML, autologous hematopoietic stem cell transplantation shows promising outcomes as an additional treatment option, according to a retrospective analysis.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, Oncologists1Tweet-
While #alloHSCT is the standard treatment for secondary AML, autologous hematopoietic stem cell transplantation (#autoHSCT) shows promising outcomes as an additional treatment option. Learn more: https://t.co/yPbqHtsw9B https://t.co/tifIsHWcFH
-
For patients with #myelofibrosis undergoing allogeneic hematopoietic stem cell transplantation, mutation driver clearance at 30 days was associated with improved cancer outcomes. Learn more: https://t.co/h7ZDFr8tiL https://t.co/HpXhIueiIw